Financials

News Ideas Technicals

1734 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to SINPHAR PHARMACEUTICAL CO LTD operating, investing, and financing activities

1734 free cash flow for Q4 23 is 60.02 M TWD. For 2023, 1734 free cash flow was 1.26 M TWD and operating cash flow was 296.77 M TWD.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—